{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T04:15:04Z","timestamp":1747282504501,"version":"3.40.5"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","funder":[{"name":"Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University","award":["GA64\/25"],"award-info":[{"award-number":["GA64\/25"]}]},{"name":"Research Fund for HIV in Children and Youth, Faculty of Medicine, Chulalongkorn University"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:p>We investigated the steady-state pharmacokinetics of generic abacavir (ABC)\/lamivudine (3TC) dispersible tablets (DTs) in young children living with HIV aged 3 months to &lt;7 years, weighing 6 to &lt;20\u2009kg. Twenty-eight Thai children were enrolled and received ABC\/3TC-DT plus pediatric dolutegravir-DT once daily. ABC\/3TC was administered using WHO weight band (WB) doses: 180\/90\u2009mg, 240\/120\u2009mg and 300\/150\u2009mg for children weighing 6 to &lt;10\u2009kg (WB 1, n = 7), 10 to &lt;14\u2009kg (WB2, n = 9) and 14 to &lt;20\u2009kg (WB3, n = 12), respectively. ABC geometric mean (GM) AUC<jats:sub>0\u201324 h<\/jats:sub> (CV%) was 14.2 (50.5%), 15.6 (32.6%) and 20.7 (28.3%) mg.h\/L, respectively, and 3TC GM AUC<jats:sub>0\u201324 h<\/jats:sub> was 14.8 (44.1%), 18.2 (28.0%) and 19.9 (26.2%) mg.h\/L, respectively. ABC and 3TC exposures were within target ranges across WBs. These data supported current ABC\/3TC-DT WHO-weight band dosing guidance for young children in Thailand.<\/jats:p>","DOI":"10.1097\/inf.0000000000004683","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T22:01:55Z","timestamp":1737151315000},"page":"428-430","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacokinetics of Generic Pediatric Abacavir\/Lamivudine Dispersible Tablets in Thai Young Children Living With HIV Weighing Below Twenty Kilograms"],"prefix":"10.1097","volume":"44","author":[{"given":"Noppadol","family":"Wacharachaisurapol","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Center of Excellence in Clinical Pharmacokinetics and Pharmacogenomics"},{"name":"Center of Excellence for Pediatric Infectious Diseases and Vaccines"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athiporn","family":"Rungsapphaiboon","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvaporn","family":"Anugulruengkitt","sequence":"additional","affiliation":[{"name":"Center of Excellence for Pediatric Infectious Diseases and Vaccines"},{"name":"Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pugpen","family":"Sirikutt","sequence":"additional","affiliation":[{"name":"Queen Sirikit National Institute of Child Health, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wipaporn Natalie","family":"Songtaweesin","sequence":"additional","affiliation":[{"name":"Center of Excellence for Pediatric Infectious Diseases and Vaccines"},{"name":"School of Global Health, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yardpiroon","family":"Tawon","sequence":"additional","affiliation":[{"name":"AMS-PHPT Research Collaboration, Faculty of Associated Medical Science, Chiang Mai University, Chiang Mai, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chayapa","family":"Phasomsap","sequence":"additional","affiliation":[{"name":"Center of Excellence for Pediatric Infectious Diseases and Vaccines"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monta","family":"Tawan","sequence":"additional","affiliation":[{"name":"Center of Excellence for Pediatric Infectious Diseases and Vaccines"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yossawadee","family":"Na Nakorn","sequence":"additional","affiliation":[{"name":"Queen Sirikit National Institute of Child Health, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim R.","family":"Cressey","sequence":"additional","affiliation":[{"name":"AMS-PHPT Research Collaboration, Faculty of Associated Medical Science, Chiang Mai University, Chiang Mai, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1873-1867","authenticated-orcid":false,"given":"Thanyawee","family":"Puthanakit","sequence":"additional","affiliation":[{"name":"Center of Excellence for Pediatric Infectious Diseases and Vaccines"},{"name":"Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"year":"2021","key":"R1-20250514","article-title":"Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach."},{"year":"2023","key":"R2-20250514","article-title":"Guidelines for the use of antiretroviral agents in pediatric HIV infection. Department of Health and Human Services."},{"key":"R3-20250514","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/INF.0000000000004366","article-title":"Pharmacokinetics of generic pediatric dolutegravir dispersible tablet in Thai young children living with HIV weighing below twenty kilograms.","volume":"43","author":"Rungsapphaiboon","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"R4-20250514","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1016\/S2352-3018(23)00107-8","article-title":"Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study.","volume":"10","author":"Brooks","year":"2023","journal-title":"Lancet HIV"},{"key":"R5-20250514","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1473-3099(15)00319-9","article-title":"Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial.","volume":"16","author":"Mulenga","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R6-20250514","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3390\/pharmaceutics15051470","article-title":"Effect of food on the pediatric dispersible tablet formulations of TRIUMEQ and DOVATO in healthy adult participants.","volume":"15","author":"Chandasana","year":"2023","journal-title":"Pharmaceutics"},{"key":"R7-20250514","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S2055-6640(20)30503-3","article-title":"Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children.","volume":"1","author":"Bunupuradah","year":"2015","journal-title":"J Virus Erad"},{"key":"R8-20250514","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/INF.0000000000003366","article-title":"Development of dolutegravir single-entity and fixed-dose combination formulations for children.","volume":"41","author":"Singh","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"R9-20250514","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/135965350701200510","article-title":"Abacavir plasma pharmacokinetics in the absence and presence of atazanavir\/ritonavir or lopinavir\/ritonavir and vice versa in HIV-infected patients.","volume":"12","author":"Waters","year":"2007","journal-title":"Antivir Ther"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004683","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T21:13:29Z","timestamp":1747257209000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004683","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"type":"print","value":"0891-3668"},{"type":"electronic","value":"1532-0987"}],"subject":[],"published":{"date-parts":[[2025,1,10]]}}}